Increased Arf/p53 activity in stem cells, aging and cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28101907.
- Also identified by DOI 10.1111/acel.12574 and PMC identifier 5334536.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Arf/p53 pathway protects the cells against DNA damage induced by acute stress. This characteristic is the responsible for its tumor suppressor activity. Moreover, it regulates the chronic type of stress associated with aging. This is the basis of its anti-aging activity. Indeed, increased gene dosage of Arf/p53 displays elongated longevity and delayed aging. At a cellular level, it has been recently shown that increased dosage of Arf/p53 delays age-associated stem cell exhaustion and the subsequent decline in tissue homeostasis and regeneration. However, p53 can also promote aging if constitutively activated. In this context, p53 reduces tissue regeneration, which correlates with premature exhaustion of stem cells. We discuss here the current evidence linking the Arf/p53 pathway to the processes of aging and cancer through stem cell regulation.
Medical subject headings
- Aging
- Cell Cycle Proteins
- Neoplasms
- Stem Cells
- Tumor Suppressor Protein p53